Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
OMVE - On watch for tomorrow? PR released EOD and closed at HOD.
NEW YORK , April 23, 2012 (GLOBE NEWSWIRE) -- Omni Ventures, Inc. (OTCQB:OMVE) announced today that Michael Berk , the celebrated Emmy and Golden Globe nominated producer, writer and director will co-chair the Advisory Board of PRVCY Couture, Inc. Mr. Berk has created and produced numerous successful TV series, most notably "Baywatch", and recently wrote the enormously successful feature film, "Soul Surfer". Mr. Berk has worked with major Motion Picture Studios, TV Production Companies and Networks, with his recent focus being on New Media and creating Branded Lifestyle Networks, earning him numerous industry awards and respect among his peers.
"Bringing Michael Berk's creative abilities to our Advisory Board will greatly expand PRVCY's celebrity branding efforts, media strategy and marketing capabilities," said Christian Wicks , President of Omni Ventures, Inc. Mr. Wicks continued, "We're confident that Michael's decades of experience will give our flagship brand PRVCY Premium the ' Hollywood edge', and that special touch of exclusivity will maintain the accessible consumer appeal that has made lifestyle exports from California a worldwide success for many years. We anticipate that together with the other members of our Advisory Board , Michael will help position PRVCY as the 'must have brand', expanding our target demographic in all markets. The value of Michael's leadership as the celebrity liaison, creative advisor and marketing and branding guru is hard to overestimate. We believe that his influence on our branding efforts will become clearly identifiable in the near future, and with his guidance the creative and innovated path to PRVCY brand awareness will soon lead to PRVCY brand insistence worldwide."
About Omni Ventures
Omni Ventures, Inc. is a versatile holding company operating in premium consumer brands development and merchandising as well as consumer services. The Company is working to position itself as a strategic management holding company for several subsidiaries including ones yet to be acquired. Currently the Company wholly owns PRVCY Couture, Inc. , the casual couture apparel and accessories design, manufacturing and distribution company (www.prvcycouture.com). Management is currently developing several related projects in the fields of consumer goods design, manufacturing and distribution as well as consumer services. For more info, please visit www.OMVE.net.
This press release may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities, and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company's ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the Company's business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company's periodic filings with the Security and Exchange Commission . The Company undertakes no obligation to update any forward-looking statements.
CONTACT: investor.relations@omve.net
913-693-8073
Source: Omni Ventures, Inc.
This is from my experience with biotechs.
Long-term wise, I definitely wouldn't go overweight with it. I'd probably only stay with companies that are well established like GSK, or Merck (MRK) for long term plays + dividends. Even then, you can find plenty of other stocks in other sectors that you'd probably be better off with.
Usually ones that are sub $10 are looking to get drugs in their pipelines approved. Without any approved drugs they don't really have revenue streams so they're speculative plays. They're ones that get hit hard if the market is in the crapper. Last summer was pretty bad for biotechs. Even when drugs got approved, there wasn't much money to be made. They'd get smashed by shorts right after the pop on good news.
I still think the markets are a little shakey so I'm really careful with which ones I chose to get in on. When the market is good, people are more willing to take chances on them. I try to only play the PDUFA dates. If the company has a PDUFA date with the FDA, that means whatever drug they're trying to get approved has been vetted through the phase trials, which cuts down on a lot of the risk. Even then, there's no guarantee they'll get approval. You can look at charts from a bunch of the sub $10 ones and see how risky they are. Here are a few I can think of off the top of my head: AEZS AVNR PLX ALXA ASTM NAVB FCSC TLON.
I try to limit the time I'm in on them. The less time you're in, the less chance you have of getting burned by them. I look for the catalysts to play. If they don't have any, I try to stay away. When they do, I decide how much I'm willing to put down based on the risk I personally perceive. Things like the market size of the drug they're trying to get approve, do they have a Service Protocol Agreements (SPA) with the FDA and have they received previous Complete Response Letters (CRLs). Just like I look to Lowtrade for technical analysis, I look to $heff for biotech fundamentals.
This is all from my experience. If anyone has anything they want to add, or dispute, feel free.
Still watching it.. may jump in within the next few trading days. $heff thinks highly of it and they're presenting at ASCO at the beginning of June or mid May. I was in it last year, if I remember correctly, and took a small hit because the info was a little less than expected. The chart has held that $4 support range so far.
Here's a seeking alpha article for the ASCO expectations. Looks good.
http://seekingalpha.com/article/465371-celldex-has-big-expectations-for-asco-12
PLX - Yup, those are biotechs for ya.
Damn thing gapped north this morning. I liked how it was trading intra-day, but the daily candle stick had me worried. Didn't know what to think of it. I was thinking it'd close down then close the gap on Monday before possibly going back up. All indicators look to be improving.
PLX Cup and Handle. On watch for me. Don't really like how it retraced to the 50%, but we'll see how the volume does. They have a PDUFA date on May 1 so be careful if you get in. I'm thinking the drug should get approved since it was declined last time for an issue that the company claims it has resolved. We'll see.
PLX - $heff, are you not interested in this one anymore?
One of my top rules when perusing penny boards:
Be more critical of anyone posting in bold.
RGEN - I sold off everything @ 6.32 for a 2% profit. Didn't like the opening action yesterday. Kudos on the heads up, kind sir. I'm keeping it on watch. They have a priority review PDUFA date on June 21st with the FDA for Secreflow (used in diagnosis of pancreatitis/pancreatic cancer and their financials are in good order).
Now, to the chart. I'm thinking the 20dma will be support? If not, a collapse to the longer term uptrend? I know this doesn't really jive with your trading style and you preach not to find the bottom that way. I'm trying to find the right mix of technical/fundamental here. Thanks again!
$heff's DD
http://chart.ly/d8dky4u
A candle tail would be expected on a day like this though, wouldn't it? May be an opportunity for some bag-holders and the people who mistimed the bottom to get out?
Thanks for that eval. That's why we gotta keep you running efficient :) I didn't consider the bump and run. Wasn't too happy with the volume today either. I took a position based on the fundamentals and chart. If it doesn't break through tomorrow, I'll lock in some of the profits, but I plan to keep a small position. Thanks for the heads up.
RGEN - Took another position @ 6.20. Going to hold this one for a little through the FDA PDUFA date.
That's good... gap's closed.
Lowtrade, covered your iHub sub for the next 6 months.
I'll probably be gone most of the time after that, but hopefully someone else here is willing to pick it up. Small price to pay for the wealth of knowledge you dole out.
If you wanna gift a subscription, click on their name and click the gift box next to their picture.
Not really much to look at. The average volume is picking up so people are becoming more interested in it and it broke the down trend. Below is Lowtrade's video on bottom bouncers. You want to see .10 break.
Here's how I interpret it. Lowtrade, feel free to opine.
Right now, it looks like it just broke below the uptrend. But, since it's really close, it could still bounce. You want it to hold the uptrend. It looks like there's support/resistance in the ~4 buck range. If it continues to break down, ~3.60 would be the next support, then 3, then somewhere sub-2.60. If it bounces up, then a long-term ascending triangle. Like Lowtrade said, double-top, not double-bottom; bottom is sub 2.20 if you look at a longer term chart. 3.60 was just a support bounce (look at a chart that shows Aug of last year). Be sure to keep an eye on Futures (link below). I keep it book marked and check it every morning pre-market. Speculative stocks like this (biotechs) will be among the first to tank if the market continues to crap. Big money stays away from them, and the shorts come in on the attack. Like I've learned from Lowtrade, the lines aren't absolute, but they give you a way to plan out your entry and exit if things go good or to crap.
http://www.finviz.com/futures.ashx
Not sure how you deduced that I was implying "nefarious groups" aren't. If a trader bought at the top, that's the trader's piss poor decision because they actively made a decision to buy. I know all of us have made the mistake; whether a penny or blue chip.
This is from my experience with biotechs. I was implying ass-clowns that short the stock intensely for a brief moment in time to knock out stops and scare people just so they can go long once the PPS has tanked. Usually because they have insider information about a drug getting approved. Yeah, I agree, there are criminals on both sides. I was only referring to this particular aspect of criminal behavior.
Lowtrade, what do you make of VRNG? Up to ~3.60 afterhours so that'll be a pretty big gap that may get filled. Also, are the fibs correct on this one? Do you not count gap, then walk downs? My reasoning would be not to since it's a manipulated open and there wasn't really a price push to that level. Manipulated is probably a bad choice of word, but I think you catch my drift.
Bear raids are downright criminal.
Yeah, with the red day on the market I expected it to try closing the gap.
Futures painting a red day.
http://www.finviz.com/futures.ashx
Most of the ones I was watching broke pattern or have crap volume. I like RGEN setting up. They have a catalyst for the end of the month and a PDUFA date sometime this summer. What else you watching?
I got stopped out on everything. Meh, hasn't been a great week.
Lowtrade, you ever partake in shorting?
Never really hear you talk about it. I know you play FAZ, which is not actually shorting... I guess someone taking your money and shorting for you? lol
I do remember in the past you mentioning something about just reading the indicators/layovers in reverse. Shorted some RAD yesterday. Made back some of the losses where I got stopped out.
It was doing good until a certain point yesterday, then it started dumping with the market. I got stopped out.
Well, stopped out on pretty much everything. Market must of had a stomach ache because it's taking a nice dump.
Yeah, I was worried about that too on the first couple of days on the retrace, but it's held above the 38% on the fibs so I'm guessing there's positive sentiment for continuation.
ARNA - Thinking this one should go. If not today, within the next couple of days.
All the green candles, to me, means big institutional money is chasing it. Seems common with biotechs. Just like RGEN's recent run. AVNR had a similar run before earnings. Seems like someone knows something's up.
Biotechs can be scary to trade. I've reaped some great rewards and have been burned just about as many times. But, if you see steady uptrends, that makes me think big money is comfortable with the risk.
Was watching this one at the close on Thursday. Hopefully it gets a bounce on Monday. It's starting to look like dumping.
Not sure what the affect of that will be. :)
Lots of pissed off people in SAVW.
Ahh got ya. A lot different than a database admin haha. That's awesome. Sounds like you're a fast burner. Not many people make it that far. Not that I need to tell you that lol
I'm doing Project Management. Wish I could finish up since I'm only a couple semesters out, but I've been waiting for four years so I'm not going to pass it up.
Good to meet you and Happy Easter, Chief.
What's DBA? I'm only familiar with Database Administrator lol. I'm so tired of school... just like everyone else. "Dissertation" is a word I hope to never have to use. Good luck with that.
Right now I'm a 3D (computer wieney), but I'm retraining into combat control so I'll be in Texas, Mississippi and here at home in Florida.